ZEJULA 200 mg/1 (Niraparib TABLET, FILM COATED) 200 mg/1

ZEJULA 200 mg tablets are a pharmaceutical product used in cancer treatment. This oral medication is designed to target specific cellular mechanisms, offering a therapeutic option for certain types of cancer.

Strength

200 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0173-0912-61)

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ZEJULA 200 mg tablets are primarily used in the treatment of ovarian cancer. This medication is often prescribed for patients who have responded to previous platinum-based chemotherapy. The active ingredient, niraparib, works by inhibiting a specific enzyme involved in DNA repair, which can help slow the growth of cancer cells. Patients may wonder, 'What is ZEJULA used for?' This medication is typically used in advanced stages of ovarian cancer to extend progression-free survival.

Side Effects

Common effects of ZEJULA 200 mg tablets may include fatigue, nausea, and anemia. Some patients might experience vomiting, thrombocytopenia, or neutropenia. It's important to note that individual responses to medication can vary, and not everyone will experience these effects. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

ZEJULA 200 mg tablets should be handled with care. Patients should follow their healthcare provider's instructions regarding dosage and administration. It's important to inform your healthcare provider about any other medications you are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Avoid Interactions

ZEJULA 200 mg tablets may interact with certain medications, including strong CYP3A inhibitors and inducers. Alcohol consumption should be avoided while taking this medication, as it may exacerbate side effects. Always inform your healthcare provider about all medications and supplements you are taking to ensure safe and effective treatment.

References

Frequently Asked Questions

ZEJULA 200 mg tablets are used in the treatment of ovarian cancer, particularly in patients who have responded to previous platinum-based chemotherapy.

ZEJULA 200 mg tablets are taken orally, typically once daily. Follow your healthcare provider's instructions for the best results.

Common side effects may include fatigue, nausea, anemia, vomiting, thrombocytopenia, and neutropenia.

ZEJULA may interact with certain medications, including strong CYP3A inhibitors and inducers. Always consult your healthcare provider before combining medications.

Pregnant women or those planning to become pregnant should discuss the risks and benefits of ZEJULA with their healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.